Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.37 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2133320 | 0.96 | KDM4E (0.52) | KDM4EALDH1A1HPGDMAPTTHRB | |
| SCHEMBL4393614 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB | |
| SCHEMBL20484784 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB | |
| Silver SCHEMBL191053 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB | |
| SCHEMBL26227 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB | |
| Lithium Ion SCHEMBL1457619 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB | |
| SCHEMBL10404578 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB | |
| Potassium Ion SCHEMBL5250865 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB | |
| SCHEMBL25283 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB | |
| SCHEMBL11433030 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115404039-B | Polyurethane adhesive and preparation method and application thereof | 杭州之江有机硅化工有限公司 | 2023-06-16 | — | — | CN | claimed |
| CN-115404039-A | Polyurethane adhesive and preparation method and application thereof | 杭州之江有机硅化工有限公司 | 2022-11-29 | — | — | CN | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| US-5128334-A | Side effect reduction, ascorbic acid or derivative | IMMUNO JAPAN INC. (JP) | 1992-07-07 | — | — | US | claimed |
| EP-0437083-A1 | Analgesic and anti-inflammatory medicine | IMMUNO JAPAN INC. (JP) | 1991-07-17 | — | — | EP | claimed |
| US-4229446-A | ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1980-10-21 | — | — | US | claimed |
| JP-56077223-A | — | — | None | — | — | JP | disclosed |
| JP-56073020-A | — | — | None | — | — | JP | disclosed |
| JP-56115719-A | — | — | None | — | — | JP | disclosed |
| US-12622949-B2 | Compositions containing rapid-acting insulin analogues | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| US-20250099551-A1 | THERMOSTABLE FORMULATION OF A21G HUMAN INSULIN | ADOCIA (FR) | 2025-03-27 | — | — | US | disclosed |
| EP-3720471-B1 | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A COPOLYAMINO ACID | ADOCIA (FR) | 2023-11-29 | — | — | EP | disclosed |
| EP-4019039-B1 | COMPOSITIONS IN THE FORM OF AN AQUEOUS INJECTABLE SOLUTION COMPRISING AT LEAST ONE HUMAN INSULIN A21G AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION | ADOCIA (FR) | 2023-10-11 | — | — | EP | disclosed |
| JP-S5677223-A | ACETYLSALICYLIC ACID TABLET | LION CORP | 1981-06-25 | — | — | JP | disclosed |
| JP-S5673020-A | TABLET OF ALUMINUM ACETYLSALICYLATE | LION CORP | 1981-06-17 | — | — | JP | disclosed |
| EP-0019000-A1 | OSTEOPLASTIC PROMOTOR | TEIJIN LIMITED (JP) | 1980-11-26 | — | — | EP | disclosed |
| US-4229446-A | ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1980-10-21 | — | — | US | disclosed |
| US-4229446-A | ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1980-10-21 | — | — | US | disclosed |
| US-4229446-A | ANALGESICS, ANTIPYRETICS, ANTIINFLAMMATORY AGENTS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1980-10-21 | — | — | US | disclosed |
| US-4019872-A | Producing sodium carbonate monohydrate from carbonate solution including addition of aluminum ions | INTERMOUNTAIN RESEARCH AND DEVELOPMENT CORPORATION (US) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622949-B2 | Compositions containing rapid-acting insulin analogues | IAPP, HBB, GLP1R | KDM4E 4417/4885ALDH1A1 4789/4885HPGD 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.